The Effect of Different Ketone Supplements on β-OHB and Blood Glucose in Healthy Individuals

NCT ID: NCT05273411

Last Updated: 2024-08-01

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-24

Study Completion Date

2022-05-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Ketone bodies are a fuel source and signaling molecule that are produced by your body during prolonged fasting or if you consistently eat at low-carbohydrate diet. Blood ketones can be used as a source of energy during fasting and are used by your brain as an alternative source of fuel to glucose. Previous studies have found that ketones, when consumed in form of a supplement drink, can increase blood ketone levels and lower blood glucose, the amount of sugar in your blood. This is of potential interest for individuals with high blood sugar, such as people living with type 2 diabetes. However, there are different types of ketone supplements that differ in how they are metabolized in the body. Little is known about how these supplements affect blood ketone and blood glucose levels. The main objective of this study is to determine the effect of three different ketone supplements on blood ketones and blood glucose. The results of this pilot study will be used to guide future research for larger and more extensive studies on ketone supplements.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ketosis Blood Glucose

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

(R)-3-hydroxybutyl (R)-3-hydroxybutyrate ketone monoester

1 x 20 mL

Group Type ACTIVE_COMPARATOR

(R)-3-hydroxybutyl (R)-3-hydroxybutyrate ketone monoester

Intervention Type DIETARY_SUPPLEMENT

Single-dose pharmacokinetic study over 4 hours.

Beta-hydroxybutyric acid

1 x 237 mL

Group Type EXPERIMENTAL

Beta-hydroxybutyric acid

Intervention Type DIETARY_SUPPLEMENT

Beta-hydroxybutyric acid

1,3-Butanediol

1 x 35 mL

Group Type EXPERIMENTAL

1,3-Butanediol

Intervention Type DIETARY_SUPPLEMENT

1,3-Butanediol

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

(R)-3-hydroxybutyl (R)-3-hydroxybutyrate ketone monoester

Single-dose pharmacokinetic study over 4 hours.

Intervention Type DIETARY_SUPPLEMENT

Beta-hydroxybutyric acid

Beta-hydroxybutyric acid

Intervention Type DIETARY_SUPPLEMENT

1,3-Butanediol

1,3-Butanediol

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Exogenous Ketones Exogenous Ketones Exogenous Ketones

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* over the age of 18;
* able to fast overnight

Exclusion Criteria

* being a competitive endurance athlete;
* following a ketogenic diet, low-calorie diet, periodic fasting regimen, or regularly consuming ketogenic supplements;
* being unable to travel to and from the university;
* being unable to follow the diet instructions;
* being pregnant or planning to become pregnant during the study;
* having been diagnosed with a chronic disorder of glucose or fat metabolism, including type 2 diabetes, chronic pancreatitis, or gallbladder disease;
* being unable to read or communicate in English
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of British Columbia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jonathan Little

Dr. Jonathan Little, Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of British Columbia Okanagan

Kelowna, British Columbia, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H22-00083

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Metabolic Effects of Non-Nutritive Sweeteners
NCT01200940 COMPLETED PHASE1/PHASE2